Centers & Labs

Congenital Heart Defects Research Program

Two students walk along a tree-lined path on Emory's campus

Overview

About Congenital Heart Defects

Congenital heart defects (CHDs) occur in approximately 1% of births per year in the United States. CHD anatomy can vary:

  • Complex anatomy, which involves severe defects requiring surgery in the first year of life
  • Shunt defects, which permit mixing of blood and do not always require intervention
  • Valve defects, which may progress over time
  • Other defects such as coronary artery anomalies 

The consequences of heart defects vary based on a number of factors including the type of defect and repair. Survival in infants with CHD through adulthood has significantly increased over the past few decades due to screening programs that allow for early detection and innovative surgical procedures that correct or modify structural defects. In addition, collaborative public health surveillance among clinicians, public health professionals, and other researchers has facilitated an environment where CHD survival can be evaluated alongside comorbidities and health care utilization to influence decision making in clinical settings.

About Our Program

The Emory Adolescent and Adult Congenital Heart Defect Program has been working collaboratively with institutions across the nation since 2012 to better understand the strengths and limitations of CHD surveillance in the U.S., describe characteristics and understand health care utilization of the adolescent and adult CHD population, and inform actions to improve health outcomes.

View Our CHD Education Modules

Four maps of the United States showing the surveillance sites at various stages of the congenital heart defects research program between 2012 and 2024


 

Projects and Publications

CHD Surveillance Projects

Since its inception, the CHD Research Program has been continuously involved in CHD surveillance across the U.S. Read about our previous and current surveillance projects here.

Funding/Support

Centers for Disease Control and Prevention, Grant/Award Number: CDC‐RFA‐DD12-1207

Surveillance Period

2008-2010

Collaborators

  1. Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, GA
  2. Emory University School of Medicine and Rollins School of Public Health, Atlanta, GA
  3. Massachusetts Department of Health, Boston, MA
  4. New York State Department of Health, Albany, NY

Priorities

  • To determine feasibility of population-based CHD surveillance across multiple sites
  • To estimate the prevalence of CHD among adolescents and adults
  • To examine survival, health care utilization, and longer term outcomes among adolescents and adults with CHD

What We Learned

  • Many U.S. children, teens, and adults live with and receive care for CHD
  • 20-33% of adolescents and adults with CHD have been diagnosed with a mental health condition
  • Many women with CHD become pregnant and experience pregnancy-related health complications
  • Severe CHD ranged from 11% (NY) to 20% (GA)
  • Medicaid coverage: > 75% (MA), 31% (GA), 28% (NY)
  • Capture of comorbid conditions varied across sites
  • Older patients and those with non-complex CHD contribute to health burden
  • Cardiac complications and comorbid conditions are common
     

Funding/Support

Centers for Disease Control and Prevention, Grant/Award Number: CDC‐RFA‐DD15-1506

Surveillance Period

2011-2013

Collaborators

  1. Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, GA
  2. Emory University School of Medicine and Rollins School of Public Health, Atlanta, GA
  3. Duke University School of Medicine, Duke Clinical Research Institute, Durham, NC
  4. New York State Department of Health, Albany, NY
  5. University of Colorado Anschutz Medical Campus, Departments of Internal Medicine and Pediatrics, Divisions of Cardiology, Aurora, CO
  6. University of Utah, Salt Lake City, UT

Priorities

  • To determine the prevalence of CHD across the lifespan, health care utilization among adolescents and adults, comorbidities, heart failure
  • To assess barriers to appropriate transition of adolescents to adult cardiac care (NY, GA)
  • To develop education modules (GA)

What We Learned

  • 24% complex anatomy, 37% shunt, 53% valve
  • 69% children
  • 19% Black or multi-racial, 15% Hispanic
  • 48% have public insurance, which is more common for children
  • Overall retention in care was low when transitioning from pediatric to adult care
  • Severe CHD individuals were more likely to transfer to adult CHD care than those with shunt and/or valve lesion
  • Transfer to adult care typically was to an adult CHD care setting
  • Barriers to care transition included concern with replacing a strong relationship with pediatric providers, concern with obtaining insurance coverage into adulthood, and inability to locate an appropriate adult provider.
     

Funding/Support

Centers for Disease Control and Prevention, Grant/Award Number: CDC‐RFA‐DD19-1902A and 1902B

Component A

Surveillance Period

2010 - 2019

Collaborators

  1. Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, GA
  2. Emory University School of Medicine and Rollins School of Public Health, Atlanta, GA
  3. University of Arizona, Department of Pediatrics, College of Medicine, Tucson, AZ
  4. Duke University School of Medicine, Duke Clinical Research Institute, Durham, NC
  5. University of Iowa, College of Public Health, Department of Epidemiology, Iowa City, IA
  6. New York State Department of Health, Albany, NY
  7. South Carolina Department of Health and Environmental Control, Columbia, SC
  8. University of Utah, Salt Lake City, UT

Priorities

  • To assess and conduct a population-based surveillance of individuals with CHD, ages 1-45 years
  • To examine descriptive epidemiology of CHD, survival, health care utilization, and comorbidities over time
  • To improve understanding of health outcomes of CHD among public health practitioners
  • To estimate age-specific mortality

Improved treatment of CHDs in the recent decades has increased survival; however, little data exist on health care utilization, comorbidities, long-term health and non-health outcomes and mortality to inform quality of life and develop effective secondary prevention strategies to address health complications among those affected. Through the expansion of an integrated surveillance system for CHD, using individual encounter level data for 2010-2019, we aimed to:

  1. Improve understanding of age-specific mortality, health care utilization, comorbidities, survival and other outcomes over time;
  2. Gain a greater understanding of the strengths and limitations of databases used for CHD surveillance; and
  3. Increase CHD awareness among the public and stakeholders.

Component B

Surveillance Period

2010 - 2019

Collaborators

  1. Emory University School of Medicine and Rollins School of Public Health, Atlanta, GA
  2. Emory University School of Medicine, Department of Biomedical Informatics, Atlanta, GA

Priorities

  • To validate billing codes for CHDs in health care claims data
  • To determine best ways to use health care claims for CHD surveillance across the lifespan

Building on existing CHD surveillance infrastructure and using individual encounter level integrated electronic health record and administrative data for 2010-2019, and through validation of health care claims data in an integrated surveillance system for CHDs, this project aimed to:

  1. Improve understanding of the validity and utility of health care claims data for surveillance of CHDs
  2. Improve the accuracy of identification and surveillance of CHDs
  3. Increase awareness among the public and stakeholders

Funding/Support

Centers for Disease Control and Prevention, Grant/Award Number: CDC-RFA-DD-24-0051A and B

Component A

Surveillance Period

2020 - 2024

Collaborators

  1. Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, GA
  2. Emory University School of Medicine and Rollins School of Public Health, Atlanta, GA
  3. Duke University School of Medicine, Duke Clinical Research Institute, Durham, NC
  4. New York State Department of Health, Albany, NY
  5. University of Utah, Salt Lake City, UT
  6. Indiana University, Bloomington, IN
  7. Texas Children’s Hospital and Baylor College of Medicine, Houston, TX

Priorities

  • To assess and conduct a population-based surveillance of individuals with CHD
  • To examine descriptive epidemiology of CHD, survival, health care utilization, and comorbidities over time
  • To improve understanding of health outcomes of CHD among public health practitioners
  • To estimate age-specific mortality

Component B

Surveillance Period

2020 - 2024

Collaborators

  1. Emory University School of Medicine and Rollins School of Public Health, Atlanta, GA
  2. Emory University School of Medicine, Department of Biomedical Informatics, Atlanta, GA

Priorities

  • To validate billing codes for CHDs in health care claims data
  • To determine best ways to use health care claims for CHD surveillance across the lifespan
     

Our People

The CHD Team

  • Wendy Book, MD, principle investigator, ACHD cardiology; director of the Adult Congenital Heart Center
  • Fred Rodriguez III, MD, co-investigator; pediatric cardiologist/adult congenital cardiologist,
    Children’s Healthcare of Atlanta & Emory Healthcare
  • Cheryl Raskind-Hood, co-investigator; research associate professor of epidemiology
  • Lindsey Ivey, assistant epidemiologist
  • Vijaya Kancherla, PhD, research assistant professor of epidemiology
  • Alex Haffner, senior data informatics specialist

Community Advisory Committee

  • Children’s Healthcare of Atlanta
  • Emory Healthcare, Adult Congenital Heart Center
  • Emory Cardiology at Grady Hospital
  • Georgia Department of Public Health, Epidemiology Division
  • Georgia Department of Community Health, Medicaid Division
  • Georgia State University, School of Public Health, Center for Leadership in Disability
  • Kids at Heart/Camp Braveheart
  • Northside Hospital - Cardiology
  • Parents of Patients with CHD
  • Patients with CHD
  • Piedmont Healthcare, Innovation Program
  • WellStar Health